Aleksander Prejbisz
Researcher Next ID · RN-041598
Researcher · Medicine
Narodowy Instytut Zdrowia Publicznego PZH – Państwowy Instytut Badawczy
Warsaw, Poland
- Works count
- 459
- Citation count
- 9,677
- H-index
- 47
- i10-index
- 137
Research interests
Publications
Metabolic syndrome – a new definition and management guidelines A joint position paper by the Polish Society of Hypertension, Polish Society for the Treatment of Obesity, Polish Lipid Association, Polish Association for Study of Liver, Polish Society of Family Medicine, Polish Society of Lifestyle Medicine, Division of Prevention and Epidemiology Polish Cardiac Society, “Club 30” Polish Cardiac So
Archives of Medical Science · 2022 · https://doi.org/10.5114/aoms/152921
Metabolic syndrome – a new definition and management guidelines A joint position paper by the Polish Society of Hypertension, Polish Society for the Treatment of Obesity, Polish Lipid Association, Polish Association for Study of Liver, Polish Society of Family Medicine, Polish Society of Lifestyle Medicine, Division of Prevention and Epidemiology Polish Cardiac Society, “Club 30” Polish Cardiac Society, and Division of Metabolic and Bariatric Surgery Society of Polish Surgeons
Archives of Medical Science · 2022 · https://doi.org/10.5114/aoms/152921
PoLA/CFPiP/PCS/PSLD/PSD/PSH guidelines on diagnosis and therapy of lipid disorders in Poland 2021
Archives of Medical Science · 2021 · https://doi.org/10.5114/aoms/141941
Genetics, prevalence, screening and confirmation of primary aldosteronism: a position statement and consensus of the Working Group on Endocrine Hypertension of The European Society of Hypertension ∗
Journal of Hypertension · 2020 · https://doi.org/10.1097/hjh.0000000000002510
Hypertension, the renin–angiotensin system, and the risk of lower respiratory tract infections and lung injury: implications for COVID-19
Cardiovascular Research · 2020 · https://doi.org/10.1093/cvr/cvaa097
Genetics, diagnosis, management and future directions of research of phaeochromocytoma and paraganglioma: a position statement and consensus of the Working Group on Endocrine Hypertension of the European Society of Hypertension
Journal of Hypertension · 2020 · https://doi.org/10.1097/hjh.0000000000002438
Biochemical Diagnosis of Chromaffin Cell Tumors in Patients at High and Low Risk of Disease: Plasma versus Urinary Free or Deconjugated O-Methylated Catecholamine Metabolites
Clinical Chemistry · 2018 · https://doi.org/10.1373/clinchem.2018.291369
Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort
The Lancet Diabetes & Endocrinology · 2017 · https://doi.org/10.1016/s2213-8587(17)30135-3
Clinical Characterization of the Pheochromocytoma and Paraganglioma Susceptibility Genes SDHA, TMEM127, MAX, and SDHAF2 for Gene-Informed Prevention
JAMA Oncology · 2017 · https://doi.org/10.1001/jamaoncol.2017.0223
Characteristics of Pediatric vs Adult Pheochromocytomas and Paragangliomas
The Journal of Clinical Endocrinology & Metabolism · 2017 · https://doi.org/10.1210/jc.2016-3829
Activation of Human T Cells in Hypertension
Hypertension · 2016 · https://doi.org/10.1161/hypertensionaha.116.07237
Adrenal vein sampling versus CT scan to determine treatment in primary aldosteronism: an outcome-based randomised diagnostic trial
The Lancet Diabetes & Endocrinology · 2016 · https://doi.org/10.1016/s2213-8587(16)30100-0
Effects of Renal Sympathetic Denervation on Blood Pressure, Sleep Apnea Course, and Glycemic Control in Patients With Resistant Hypertension and Sleep Apnea
Hypertension · 2011 · https://doi.org/10.1161/hypertensionaha.111.173799
Cardiovascular manifestations of phaeochromocytoma
Journal of Hypertension · 2011 · https://doi.org/10.1097/hjh.0b013e32834a4ce9
Current projects
No projects listed.